Clinical Trials for Respiratory Syncytial Virus Vaccination

Find clinical trials for respiratory syncytial virus vaccination. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

NCT ID: NCT06984094

This clinical trial is a first-of-its-kind study that aims to test the safety and immune response of two new vaccines, SCB-1022 and SCB-1033, designed to protect against respiratory syncytial virus...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, Southern Australia, Australia

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

NCT ID: NCT06850051

This clinical trial is studying the safety and effectiveness of new vaccines designed to protect against several respiratory viruses, including influenza and others like respiratory syncytial virus...

Recruiting

Phase: PHASE1 Type: interventional Locations: Camberwell, Victoria, Australia, Blacktown, New South Wales, Australia +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions